Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Abera Bioscience | ABERA | Apr 18, 2024 | 4.85 | -6.37 |
Abliva | ABLI | Apr 18, 2024 | 0.16 | -0.86 |
Active Biotech | ACTI | Apr 18, 2024 | 0.55 | -2.48 |
AcuCort | ACUC | Apr 18, 2024 | 0.55 | -4.83 |
Aegirbio | AEGIR | Apr 18, 2024 | 0.54 | -3.40 |
Alligator Bioscience | ATORX | Apr 18, 2024 | 1.04 | -0.76 |
AlzeCure Pharma | ALZCUR | Apr 18, 2024 | 2.00 | -3.85 |
Alzinova | ALZ | Apr 18, 2024 | 1.75 | -1.13 |
Amniotics | AMNI | Apr 18, 2024 | 0.00 | -2.56 |
Annexin Pharmaceuticals | ANNX | Apr 18, 2024 | 0.27 | -0.37 |
Aptahem | APTA | Apr 18, 2024 | 0.03 | +2.61 |
Arcede Pharma AB | ARCEDE | Apr 18, 2024 | 0.11 | +0.46 |
AroCell | AROC | Apr 18, 2024 | 0.38 | +1.33 |
Asarina Pharma | ASAP | Apr 18, 2024 | 0.89 | 0.00 |
Ascelia Pharma | ACE | Apr 18, 2024 | 13.88 | -0.14 |
AstraZeneca | AZN | Apr 18, 2024 | 1 497.00 | -0.40 |
Attana | ATANA | Apr 18, 2024 | 0.07 | -1.43 |
Bio-Works Technologies | BIOWKS | Apr 18, 2024 | 3.90 | +3.17 |
BioArctic B | BIOAB | Apr 18, 2024 | 193.80 | -1.62 |
BioGaia B | BIOGB | Apr 18, 2024 | 118.50 | -1.25 |
BioInvent International | BINV | Apr 18, 2024 | 23.95 | +11.40 |
Biosergen | BIOSGN | Apr 18, 2024 | 0.48 | +6.89 |
Biovica International B | BIOVICB | Apr 18, 2024 | 2.30 | -2.75 |
Calliditas Therapeutics | CALTX | Apr 18, 2024 | 102.00 | +1.09 |
Camurus | CAMX | Apr 18, 2024 | 473.60 | -4.86 |
Cantargia | CANTA | Apr 18, 2024 | 3.80 | -4.47 |
Cereno Scientific B | CRNOB | Apr 18, 2024 | 4.31 | -0.14 |
Chordate Medical Holding | CMH | Apr 18, 2024 | 0.05 | -0.74 |
Chosa Oncology AB | CHOSA | Apr 18, 2024 | 0.94 | -0.21 |
Cline Scientific B | CLINEB | Apr 18, 2024 | 0.17 | -0.29 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.